Showing results (141-150 of 174) with videos related to
Sort By:
Pageof 18
Toxins|March 31, 2019
Arecoline Promotes Migration of A549 Lung Cancer Cells through Activating the EGFR/Src/FAK PathwayChih-Hsiang Chang, Mei-Chih Chen, Te-Huan Chiu, et al.Oncotarget|July 25, 2016
Higher frequency but random distribution of EGFR mutation subtypes in familial lung cancer patientsKuo-Hsuan Hsu, Jeng-Sen Tseng, Chih-Liang Wang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 9, 2011
EGFR L858R mutation and polymorphisms of genes related to estrogen biosynthesis and metabolism in never-smoking female lung adenocarcinoma patientsShi-Yi Yang, Tsung-Ying Yang, Kun-Chieh Chen, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 23, 2011
Epidermal growth factor receptor mutation status in stage I lung adenocarcinoma with different image patternsKuo-Hsuan Hsu, Kun-Chieh Chen, Tsung-Ying Yang, et al.Cancer Discovery|April 11, 2022
Sunvozertinib, a Selective EGFR Inhibitor for Previously Treated Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion MutationsMengzhao Wang, James Chih-Hsin Yang, Paul L Mitchell, et al.International Journal of Cancer|May 11, 2012
EGFR exon 19 in-frame deletion and polymorphisms of DNA repair genes in never-smoking female lung adenocarcinoma patientsShi-Yi Yang, Tsung-Ying Yang, Yao-Jen Li, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 25, 2025
Trastuzumab Deruxtecan in Patients with HER2-Overexpressing Non-Small Cell Lung Cancer: Results From Part 1 of the Open-label, Multicenter, Phase 1b DESTINY-Lung03 TrialDavid Planchard, Hye Ryun Kim, Thatthan Suksombooncharoen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 2, 2023
CNS Efficacy of Osimertinib With or Without Chemotherapy in Epidermal Growth Factor Receptor-Mutated Advanced Non-Small-Cell Lung CancerPasi A Jänne, David Planchard, Kunihiko Kobayashi, et al.The New England Journal of Medicine|October 17, 2025
Sevabertinib in Advanced <i>HER2</i>-Mutant Non-Small-Cell Lung CancerXiuning Le, Tae Min Kim, Herbert H Loong, et al.Cancers|March 27, 2020
Landscape of Mitochondria Genome and Clinical Outcomes in Stage 1 Lung AdenocarcinomaLovely Raghav, Ya-Hsuan Chang, Yi-Chiung Hsu, et al.Pageof 18